3b Blackbio Dx Ltd vs Aster Dm Quality Care Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of 3B Blackbio DX Ltd is ₹ 1332 as of 23 Oct 15:30 . The P/E Ratio of 3B Blackbio DX Ltd changed from 1.9 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe P/E Ratio of Aster DM Quality Care Ltd changed from 46.2 on March 2021 to 89.7 on March 2026 . This represents a CAGR of 11.69% over 6 years The Market Cap of 3B Blackbio DX Ltd changed from ₹ 213.76 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe Market Cap of Aster DM Quality Care Ltd changed from ₹ 6858 crore on March 2021 to ₹ 34794 crore on March 2026 . This represents a CAGR of 31.08% over 6 years The revenue of 3B Blackbio DX Ltd for the Jun '26 is ₹ 39.63 crore as compare to the Mar '26 revenue of ₹ 45.58 crore. This represent the decline of -13.05% The revenue of Aster DM Quality Care Ltd for the Jun '26 is ₹ 1347 crore as compare to the Mar '26 revenue of ₹ 1218 crore. This represent the growth of 10.57% The ebitda of 3B Blackbio DX Ltd for the Jun '26 is ₹ 14.67 crore as compare to the Mar '26 ebitda of ₹ 18.64 crore. This represent the decline of -21.3% The ebitda of Aster DM Quality Care Ltd for the Jun '26 is ₹ 178.58 crore as compare to the Mar '26 ebitda of ₹ 260.58 crore. This represent the decline of -31.47% The net profit of 3B Blackbio DX Ltd changed from ₹ 11.3 crore to ₹ 8.98 crore over 9 quarters. This represents a CAGR of -9.71% The net profit of Aster DM Quality Care Ltd changed from ₹ 5152 crore to ₹ 29.28 crore over 9 quarters. This represents a CAGR of -89.95% The Dividend Payout of 3B Blackbio DX Ltd changed from 391.92 % on March 2021 to 8.69 % on March 2026 . This represents a CAGR of -47.00% over 6 yearsThe Dividend Payout of Aster DM Quality Care Ltd changed from 3818 % on March 2024 to 58.04 % on March 2026 . This represents a CAGR of -75.23% over 3 years .

About 3B Blackbio DX Ltd

3D Blackbio DX Limited, formerly known as Kilpest India Limited was incorporated on May 25, 1972 as one of India's leading agro-business companies.
Thereafter, the holding Company, Kilpest India Limited got merged with 3B BlackBio Biotech India Limited and as per the Scheme of Amalgamation, the name of the Company was changed from Kilpest India Limited to 3B BlackBio DX Limited in August, 2023. The Company is a leading Indian biotech firm focused on molecular diagnostics (PCR kits, enzymes, reagents for diseases like cancer/ infectious diseases) under the 'TRUPCR' brand, alongside developing Next-Gen Sequencing (NGS) assays (TRUNGS) & Rapid Tests (TRURAPID), while continuing its traditional agrochemicals business (pesticides, bio-products), serving both labs and government sectors, driven by R&D for innovative solutions.

About Aster DM Healthcare Ltd

Aster DM Healthcare Limited was erstwhile established as 'Aster DM Healthcare Private Limited', a private limited company on 18 January, 2008.
On November 29, 2013.
The Company was converted into a public limited company and the name of the Company was changed to Aster DM Healthcare Limited. Aster DM Healthcare Limited is one of the leading healthcare player in the GCC and India.
Founded in 1987 by Dr. Azad Moopen, the Company has emerged as an integrated healthcare service organization that provides the complete circle of care to people through network of hospitals, clinics, labs and pharmacies, providing primary, secondary, tertiary to quaternary care to all segments of the population. Aster DM offer a diverse portfolio of specialised brands that serve patients in Primary, Secondary, Tertiary, and Quaternary Care, Healthcare Retailing, Diagnostic Laboratories, Digital Health, and Medical Education.

FAQs for the comparison of 3B Blackbio DX Ltd and Aster DM Quality Care Ltd

Which company has a larger market capitalization, 3B Blackbio DX Ltd or Aster DM Healthcare Ltd?

Market cap of 3B Blackbio DX Ltd is 1,144 Cr while Market cap of Aster DM Healthcare Ltd is 56,222 Cr

What are the key factors driving the stock performance of 3B Blackbio DX Ltd and Aster DM Healthcare Ltd?

The stock performance of 3B Blackbio DX Ltd and Aster DM Healthcare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for 3B Blackbio DX Ltd and Aster DM Healthcare Ltd?

As of October 25, 2026, the 3B Blackbio DX Ltd stock price is INR ₹1332.95. On the other hand, Aster DM Healthcare Ltd stock price is INR ₹645.0.

How do dividend payouts of 3B Blackbio DX Ltd and Aster DM Healthcare Ltd compare?

To compare the dividend payouts of 3B Blackbio DX Ltd and Aster DM Healthcare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.